# Relaxed multi-module round-2 P1-T audit

> Date: 2026-06-21
> Scope: P1 concrete-module boundary follow-up focused on `ASD-0773`.
> Rule: only high-confidence changes supported by first-hand paper evidence, official project assets, or other authoritative first-hand sources are written back to the master list and Notes.

## 本轮结论

本轮关闭 1 条 `07 / 06` 边界记录：

| ID | Title short | Sources checked | Decision | Note action |
|---|---|---|---|---|
| `ASD-0773` | Skill-Augmented Medical Research Analysis | arXiv abstract `2606.11830`; arXiv HTML / PDF `2606.11830v1`; official AIPOCH medical-research-skills repository | kept `scientific_object_modules=07`; keep `primary_module_for_filing=07` | revised `Notes/07_Medical_and_Health_Sciences/Yao_2026_Skill_Augmented_Medical_Research_Analysis.md` |

## Evidence summary

### `ASD-0773` Skill-Augmented AI Agents for Medical Research Analysis

- Agent evidence: the paper evaluates a skill-augmented AI agent with autonomous skill routing in an OpenClaw environment rather than single-turn question answering.
- `07` evidence: the unified task is explicitly to construct a multi-gene signature for predicting immunotherapy response in NSCLC, and the expert evaluation criteria remain anchored in cohort design, endpoint definition, biomarker construction, immune analysis, modeling, validation, and medical-research workflow quality.
- Why `06` is not accepted: the paper contains transcriptomics, pathway-enrichment, and programmed-cell-death language, but the first-hand full text explicitly narrows these to benchmark-task workflow scope. Section 2.5 describes the deployed skills as broad bioinformatics / biomedical-research workflow modules rather than disease- or mechanism-specific NSCLC programmed-cell-death modules. The same section and Section 4.4 state that dedicated ferroptosis / cuproptosis / pyroptosis gene-set curation was not independently validated and that the study did not verify the biological validity of proposed programmed-cell-death gene sets or biomarkers. The paper's reported outputs are human-rated research-analysis artifacts, not independently reported life-science mechanism results.
- Why the boundary is now closed: under the current relaxed rule, additional `06` requires recognizable life-science object result coverage rather than merely omics-flavored task prompts or general bioinformatics workflow modules. Here the stable object remains disease-facing translational biomarker research in NSCLC, while the life-science language is explicitly framed as task scope and stress-test content.
- Accepted action: close the `07 / 06` boundary as `07` only, while keeping `07` as the relaxed primary filing direction.

## Count update

Post-P1-T relaxed overlay counts are unchanged relative to the corrected post-P1-S baseline:

| Scientific object module | Expanded assignment count |
|---|---:|
| `01` | 55 |
| `02` | 37 |
| `03` | 82 |
| `04` | 110 |
| `05` | 35 |
| `06` | 77 |
| `07` | 72 |
| `08` | 3 |
| `09` | 36 |
| `10` | 24 |
| `11` | 35 |

| Metric | Count |
|---|---:|
| Record-level confirmed included-and-classified count | 451 |
| Expanded module assignment count | 564 |
| Independent `01.04` general-method bucket count | 20 |

## Remaining uncertainty

- The current first-hand evidence is sufficient to reject additional `06` under the relaxed object-coverage rule.
- The main residual risk for this record remains core-strength and evaluation-strength, not top-level module drift.
